Epigenetic priming of a pre-B cell-specific enhancer through binding of Sox2 and Foxd3 at the ESC stage.

Cell Stem Cell
Daniel LiberNiall Dillon

Abstract

Modifications to the core histones are thought to contribute to ESC pluripotency by priming tissue-specific promoters and enhancers for later activation. However, it is unclear how these marks are targeted in ESCs and maintained during differentiation. Here, we show that the ESC factor Sox2 targets H3K4 methylation to monovalent and bivalent domains. In ESCs, Sox2 contributes to the formation of a monovalent mark at an enhancer in the pro/pre-B cell-specific lambda5-VpreB1 locus. Binding of Foxd3 suppresses intergenic transcription of the enhancer and surrounding sequences. In pro-B cells, enhancer activity is dependent on the Sox and Fox binding sites, and the enhancer is bound by Sox4, which is required for efficient expression of lambda5. Our results lead us to propose a factor relay model whereby ESC factors establish active epigenetic marks at tissue specific elements before being replaced by cell type-specific factors as cells differentiate.

References

Aug 11, 2001·Science·W M RideoutR Jaenisch
Oct 17, 2002·Genes & Development·Lynn A HannaPatricia A Labosky
Jan 7, 2003·Genes & Development·Ariel A AvilionRobin Lovell-Badge
Nov 24, 2004·The International Journal of Developmental Biology·Richard A Lang
Jul 28, 2005·Bioinformatics·Hongkai Ji, Wing Hung Wong
Nov 22, 2005·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Henrietta Szutorisz, Niall Dillon
Mar 30, 2006·Nature Cell Biology·Véronique AzuaraAmanda G Fisher
Jun 23, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Guangjin PanDuanqing Pei
Jul 5, 2006·Nature Immunology·Hui HuAnjana Rao
Oct 18, 2006·Proceedings of the National Academy of Sciences of the United States of America·Tae-Young RohKeji Zhao
Jan 11, 2007·Cell Research·Guangjin Pan, James A Thomson
Mar 17, 2007·Nature Reviews. Genetics·Mikhail Spivakov, Amanda G Fisher
Apr 19, 2007·Nature Immunology·César CobaledaMeinrad Busslinger
Jul 13, 2007·The International Journal of Biochemistry & Cell Biology·Véronique LefebvreBhattaram Pallavi
Jul 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Jian XuStephen T Smale
Sep 11, 2007·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Masashi InoueHisato Kondoh
May 9, 2008·Cell Stem Cell·Sol EfroniEran Meshorer
Jul 26, 2008·Stem Cells·Ying Liu, Patricia A Labosky
Dec 25, 2008·Cell Cycle·Sol EfroniEran Meshorer
Mar 11, 2009·Nature Reviews. Genetics·Sridhar Hannenhalli, Klaus H Kaestner
Mar 20, 2010·Current Opinion in Cell Biology·Paul D Kaufman, Oliver J Rando
Mar 20, 2010·Nature Reviews. Genetics·Raphaël Margueron, Danny Reinberg

❮ Previous
Next ❯

Citations

Mar 7, 2014·Nature Structural & Molecular Biology·Edwin Smith, Ali Shilatifard
Jun 19, 2012·Annual Review of Genomics and Human Genetics·Glenn A MastonMichael R Green
Mar 2, 2011·Nature Reviews. Genetics·Chin-Tong Ong, Victor G Corces
Apr 12, 2011·Molecular Cancer Research : MCR·Pragati Katiyar, Andrew E Aplin
Nov 8, 2011·Genes & Development·Kenneth S Zaret, Jason S Carroll
Jan 16, 2013·Stem Cells and Development·Michael T SuflitaPatricia A Labosky
Mar 14, 2013·Nucleic Acids Research·Kyoung-Jae WonWei Wang
Sep 12, 2012·Cellular and Molecular Life Sciences : CMLS·Olga ØstrupPhilippe Collas
Oct 20, 2012·Cellular and Molecular Life Sciences : CMLS·Seyed Mehdi JafarnejadGang Li
Aug 8, 2012·Nature Reviews. Genetics·François Spitz, Eileen E M Furlong
May 8, 2013·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Alvaro Rada-IglesiasJoanna Wysocka
May 8, 2013·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Serena Ghisletti, Gioacchino Natoli
Sep 10, 2013·Seminars in Nephrology·Yi-An Ko, Katalin Susztak
Apr 11, 2012·Trends in Genetics : TIG·Christa Buecker, Joanna Wysocka
Sep 3, 2011·Trends in Genetics : TIG·Luca MagnaniMathieu Lupien
Jul 22, 2014·Experimental Dermatology·Marek JankowskiRafal Czajkowski
Nov 26, 2015·Trends in Genetics : TIG·Douglas Vernimmen, Wendy A Bickmore
Jan 17, 2012·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Niall Dillon
Apr 12, 2012·EMBO Reports·Chin-Tong Ong, Victor G Corces
Aug 16, 2014·Immunological Reviews·Deborah R Winter, Ido Amit
Nov 26, 2013·Stem Cell Research·Jennifer L PlankPatricia A Labosky
Jun 26, 2015·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Kranthi VaralaGloria M Coruzzi
Mar 31, 2015·Seminars in Immunology·Simona Saccani, Michele Trabucchi
Feb 27, 2015·Cellular and Molecular Life Sciences : CMLS·Maksim ErokhinDarya Chetverina
Apr 9, 2011·Cell Stem Cell·Kyle M Loh, Bing Lim
Feb 8, 2011·Cell·Michael Bulger, Mark Groudine
Jun 15, 2011·Cell·Stuart H Orkin, Konrad Hochedlinger
Oct 17, 2013·Journal of Molecular Endocrinology·Dawn X Zhang, Christopher K Glass
Apr 18, 2019·Nature Communications·Hiroya IshiharaSachihiro Matsunaga
Dec 30, 2014·Physiological Reviews·Kyle M LohLay Teng Ang
Oct 3, 2013·Development·Yusuke Kamachi, Hisato Kondoh
Jun 12, 2014·Development·Wee-Wei Tee, Danny Reinberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

B cells: Gene Expression

B lymphocytes are white blood cells that play a role in the adaptive immune system by secreting antibodies. Here is the latest research on gene expression in B cells.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.